Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Understanding hair health and disorders is important for effective treatment.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Obese people have more and worse skin problems than those of normal weight.

Hair cortisol can indicate animal stress but varies with many factors.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Hair cortisol is a reliable way to measure long-term stress in animals.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Improving diet and lifestyle can help manage skin conditions linked to insulin resistance and inflammation.

Alopecia in gray bats is most common and severe during lactation, likely due to stress and nutrition.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

Bee venom, fig, and geranium oil can effectively treat skin conditions and are safer alternatives to some conventional drugs.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Extracts from Alnus sibirica and oregonin may help with hair growth and prevent hair loss.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.